Complera has been assigned to pregnancy category B by the FDA.
Animal studies have failed to reveal evidence of embryofetal toxicity or teratogenicity.
The effects of Complera in human pregnancy has not been fully studied.
You should discuss the risks of taking this medicine with your doctor.
For more information see: https://www.drugs.com/pregnancy/emtricitabine-rilpivirine-tenofovir.html
- Complera Information for Consumers
- Complera Information for Healthcare Professionals (includes dosage details)
- Side Effects of Complera (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 8 May 2012 • 3 answers
Posted 12 Jun 2013 • 2 answers
Posted 20 Apr 2016 • 0 answers
Posted 18 Oct 2016 • 0 answers
Posted 25 Jul 2017 • 0 answers